Researchers with the Ovarian Cancer Research (OvCaRe) program at the BC Cancer Agency and Vancouver Coastal Health Research Institute found a major new tumour-suppressing gene — ARID1A. Mutations are frequent in this gene and inhibit the gene’s suppressing abilities in two types of ovarian cancer — clear cell carcinoma and endometrioid carcinoma.